|
2026
|
Invention
|
Rsv inhibitor, pharmaceutical composition thereof and use thereof. The present invention belongs ... |
|
|
Invention
|
Sirna for inhibiting apoc3 gene expression and use thereof. Provided are an siRNA, an siRNA conju... |
|
|
Invention
|
Lp(a)-targeting double-stranded sirna agent and use thereof. The present invention provides a Lp(... |
|
|
Invention
|
Purification method for galantamine intermediate. The present invention relates to the field of c... |
|
|
Invention
|
Tetrahydropyrazolopyridine derivative and use thereof. The present invention relates to the field... |
|
|
Invention
|
Agt-targeting double-stranded sirna agent and use thereof. Provided in the present invention are ... |
|
|
Invention
|
New amide pyrrole compound and use thereof in drugs. The present invention relates to a new amide... |
|
|
Invention
|
Antisense oligonucleotide for inhibiting expression of hepatitis b virus. The present invention p... |
|
|
Invention
|
Preparation method for substituted urea derivative. Disclosed in the present invention is a prepa... |
|
2025
|
Invention
|
Substituted indene compounds and use thereof. The present invention belongs to the field of pharm... |
|
|
Invention
|
Substituted indene compound and use thereof. The present invention relates to the pharmaceutical ... |
|
|
Invention
|
Bispecific antibody and use thereof. A bispecific antibody and a use thereof. The bispecific anti... |
|
|
Invention
|
Anti-4-1bb antibody and use thereof. An anti-4-1BB antibody and a use thereof. The antibody or an... |
|
|
Invention
|
Use of fgf21/glp-1 fusion protein. Provided is use of an FGF21/GLP-1 fusion protein in the prepar... |
|
|
Invention
|
Kras inhibitor compound, and pharmaceutical composition and use thereof. The present invention re... |
|
|
Invention
|
Fgf21 variant polypeptide molecules and application thereof.
An FGF21 polypeptide has one or mor... |
|
|
Invention
|
Agt-targeting double-stranded sirna, conjugate thereof, and use thereof. Provided are an AGT-targ... |
|
|
Invention
|
Heterocyclic fused ring compounds, pharmaceutical compositions thereof, and uses thereof. The pre... |
|
|
Invention
|
Myt1 kinase inhibitor, pharmaceutical composition thereof, and use thereof. The present invention... |
|
|
Invention
|
Kras inhibitor compound, pharmaceutical composition thereof and use thereof. The present inventio... |
|
2024
|
Invention
|
Composition of non-steroidal anti-inflammatory drug. The present invention relates to a non-stero... |
|
|
Invention
|
Apalutamide nanoparticle and preparation method therefor. An apalutamide nanoparticle and prepara... |
|
|
Invention
|
Novel compound and use thereof. The present invention provides a novel compound and a use thereof... |
|
|
Invention
|
Chimeric antigen receptor targeting ly6g6d and use thereof. Provided are a chimeric antigen recep... |
|
|
Invention
|
Antibody targeting ly6g6d and use thereof. Provided are an antibody targeting Ly6G6D and a use th... |
|
|
Invention
|
Ly6g6d-targeted nanobody and use thereof. Provided are a Ly6G6D-targeted nanobody and a use there... |
|
|
Invention
|
Substituted nitrogen-containing bicyclic compound and use thereof. The present invention relates ... |
|
|
Invention
|
Method for preparing pyrrole carboxylate compound. This invention discloses a method for preparin... |
|
|
Invention
|
Method for preparing pyrrole amide compound and intermediate of pyrrole amide compound. This inve... |
|
|
Invention
|
Glp-1-fc-fgf21 double-target fusion protein composition, and injection and use thereof. A GLP-1-F... |
|
|
Invention
|
Novel double-stranded sirna, conjugate thereof, and use thereof. The present invention provides a... |
|
|
Invention
|
Anti-fgfr2 antibody and use thereof |
|
|
Invention
|
Novel targeting compound and use thereof, and nucleic acid conjugate and use thereof |
|
|
Invention
|
Kras inhibitor compound, pharmaceutical composition thereof, and use thereof. The present inventi... |
|
|
Invention
|
Pyridopyrimidine derivative and use thereof.
The technical field of medicine, relates to a pyrid... |
|
|
Invention
|
Pyridopyrimidine derivative and use thereof |
|
2023
|
Invention
|
Crystal form of fluorine-substituted indazole compound and use thereof.
A crystal form of a fluo... |
|
|
Invention
|
Crystal form of fluorine-substituted indazole compound and use thereof |
|
|
P/S
|
Antidiabetic pharmaceutical preparations; Pharmaceutical preparations for the treatment of diabetes |
|
|
Invention
|
Glp-1/gcg/gip triple-receptor agonist and use thereof |
|
|
Invention
|
Claudin18.2 humanized antibody and application thereof.
A Claudin18.2 humanized antibody and app... |
|
|
Invention
|
Method for preparing pyrrole compound and intermediate thereof.
A method for preparing a pyrrole... |
|
|
Invention
|
Method for preparing pyrrole compound and intermediate thereof. The present application relates t... |
|
2022
|
Invention
|
New crystal form of nitrogen-containing tricyclic compound and use thereof.
A new crystal form o... |
|
|
Invention
|
Antifibrotic composition.
An antifibrotic composition includes 3-(4-(dihexylamino)-3-fluoropheny... |
|
|
Invention
|
Glp-1/gip dual-targeted polypeptide and fusion protein and applications thereof.
A GLP-1/GIP dua... |
|
2021
|
Invention
|
Cldn18.2 antibody and use thereof.
An antibody, or an antigen-binding fragment thereof, or a chi... |
|
2010
|
P/S
|
Pharmaceutical preparations, namely generic drugs. |
|
2009
|
P/S
|
Medicines for human purposes; pharmaceutical preparations; adjuvants for medical purposes; chemic... |
